)
Edge23 Jan 2026
Death, Taxes, and Garbage: The Story of WM
How Waste Management turned garbage into one of America's most stable business models through landfills, regulation, and nationwide scale.
WuXi AppTec
WuXi AppTec (603259) investor relations material
WuXi AppTec 44th Annual J.P. Morgan Healthcare Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.44th Annual J.P. Morgan Healthcare Conference summary14 Jan, 2026
Strategic highlights and industry context
Announced a positive profit alert for 2025, with final results and 2026 guidance to be disclosed in March.
Emphasized the integrated CRDMO platform supporting drug development from discovery to commercial manufacturing.
Noted strong industry demand, especially in GLP-1 and peptide drugs, and ongoing challenges in biotech development cycles.
Focuses on three core business segments: Wuxi Chemistry, Wuxi Biology, and Wuxi Testing, providing end-to-end solutions.
Stressed commitment to operational excellence, customer focus, and global expansion.
Financial performance and growth
Achieved record 2025 revenue of RMB 45.5 billion, up 21.4% YoY, and adjusted net profit of RMB 15 billion, up 41.3%, with a net profit margin of 32.9%, up 5.9 percentage points.
Backlog exceeded RMB 55 billion, supporting future growth.
Free cash flow reached a new record, with CapEx expected at RMB 5.5–6 billion in 2025.
Basic earnings per share improved nearly 10x since IPO, with RMB 20 billion returned to shareholders via dividends and buybacks.
Returned RMB 7 billion to shareholders in 2025 via dividends and buybacks, over 70% of 2024 net profit.
Operational achievements and capacity expansion
Expanded small molecule API reactor volume to over 4 million liters and solid phase peptide synthesizer capacity to 100,000+ liters.
Supported 3,400+ molecules in the CDMO pipeline, with 621 added in the first three quarters of 2025.
Supported 16% of global clinical stage small molecule new drugs and 27% of FDA-approved small molecule drugs in 2025.
Tides business expected to grow revenue by over 90% in 2025, with further capacity investments planned for 2026.
Currently supports 24 GLP-1 drugs, securing 25% market share in this fast-growing segment.
TIDES capacity expansion plans for 2026
What drives CRDMO internal molecule conversion?
US customer demand amid policy concerns
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next WuXi AppTec earnings date
H2 202524 Mar, 2026
WuXi AppTec
Next WuXi AppTec earnings date
H2 202524 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
WuXi AppTec Co. Ltd is a global pharmaceutical and healthcare services company based in Shanghai, China. It provides a wide range of research, development, and manufacturing services tailored to the pharmaceutical, biotech, and medical device industries. Its offerings span across various areas including small molecule drugs, cell therapies, and gene therapies, as well as medical device testing. The company is headquartered in Shanghai, China, and its shares are listed on the Hong Kong Stock Exchange.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage